A Trial of Hetrombopag in Healthy Subjects

Summary

This is a single-center, single-arm, open-label, self-controlled, phase I clinical study. A total of 26 male or female healthy subjects are intended to be enrolled to evaluate the PK drug-drug interaction between ciclosporin and hetrombopag.

Timeline

Start

2020-09-03

Primary completion

2020-10-22

Completion

2020-10-22

Drugs

Indications